Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25136996 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maiara Carolina Perussolo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Therapy and Cellular Biotechnology in Regenerative Medicine Department, The Pelé Pequeno Príncipe Research Institute, Child and Adolescent H…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Pelé Pequeno Príncipe Institute, Child, the Adolescent Health Research (State of Paraná- Brazil), Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil.
Abstract (Originalsprache)
This study aims to evaluate and compare cellular therapy with human Wharton’s jelly (WJ) mesenchymal stem cells (MSCs) and neural precursors (NPs) in experimental autoimmune encephalomyelitis (EAE), a preclinical model of Multiple Sclerosis. MSCs were isolated from WJ by an explant technique, differentiated to NPs, and characterized by cytometry and immunocytochemistry analysis after ethical approval. Forty-eight rats were EAE-induced by myelin basic protein and Freund’s complete adjuvant. Forty-eight hours later, the animals received intraperitoneal injections of 250 ng/dose of Bordetella pertussis toxin. Fourteen days later, the animals were divided into the following groups: a. non-induced, induced: b. Sham, c. WJ-MSCs, d. NPs, and e. WJ-MSCs plus NPs. 1 × 105. Moreover, the cells were placed in a 10 µL solution and injected via a stereotaxic intracerebral ventricular injection. After ten days, the histopathological analysis for H&E, Luxol, interleukins, and CD4/CD8 was carried out. Statistical analyses demonstrated a higher frequency of clinical manifestation in the Sham group (15.66%) than in the other groups; less demyelination was seen in the treated groups than the Sham group (WJ-MSCs, p = 0.016; NPs, p = 0.010; WJ-MSCs + NPs, p = 0.000), and a lower cellular death rate was seen in the treated groups compared with the Sham group. A CD4/CD8 ratio of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Therapy and Cellular Biotechnology in Regenerative Medicine Department, The Pelé Pequeno Príncipe Research Institute, Child and Adolescent Health Research & Pequeno Príncipe Faculties, Curitiba P.O. Box 80240-0…
- Experimental Laboratory of the Institute of Biology and Health Sciences, Pontifical Catholic University of Paraná, Curitiba P.O. Box 80215-901, Paraná, Brazil.
- Laboratory of Experimental Pathology, Graduate Program of Health Sciences, School of Medicine, Pontifical Catholic University of Paraná (PUCPR), Curitiba P.O. Box 80215-901, Paraná, Brazil.
- Postgraduate Program in Food, Nutrition and Food Engineering, Institute of Biosciences, Humanities and Exact Sciences (IBILCE), São Paulo State University (UNESP), São José do Rio Preto P.O. Box 15054-000, São Paulo, Br…
- Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
ORCID-Profile: Maiara Carolina Perussolo, Bassam Felipe Mogharbel, Nathalia Barth de Oliveira, Larissa Lührs, Luiz Cesar Guarita-Souza, Seigo Nagashima, Caroline Busatta Vaz de Paula, Lucia de Noronha, Katherine Athayde Teixeira de Carvalho
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Pelé Pequeno Príncipe Institute, Child, the Adolescent Health Research (State of Paraná- Brazil)
- Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil
Zitieren
APA
Perussolo, M. C., Mogharbel, B. F., Saçaki, C. S., Rosa, N. N. D., Irioda, A. C., Oliveira, N. B., Appel, J. M., Lührs, L., Meira, L. F., Guarita-Souza, L. C., Nagashima, S., Paula, C. B. V., Noronha, L., Zotarelli-Filho, I. J., Abdelwahid, E., & Carvalho, K. A. T. (2024). Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136996
Vancouver
Perussolo MC, Mogharbel BF, Saçaki CS, Rosa NND, Irioda AC, Oliveira NB, et al. Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136996
BibTeX
@article{Perussolo2024,
author = {Perussolo, Maiara Carolina and Mogharbel, Bassam Felipe and Saçaki, Cláudia Sayuri and Rosa, Nádia Nascimento da and Irioda, Ana Carolina and Oliveira, Nathalia Barth de and Appel, Julia Maurer and Lührs, Larissa and Meira, Leanderson Franco and Guarita-Souza, Luiz Cesar and Nagashima, Seigo and Paula, Caroline Busatta Vaz de and Noronha, Lucia de and Zotarelli-Filho, Idiberto José and Abdelwahid, Eltyeb and Carvalho, Katherine Athayde Teixeira de},
title = {Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25136996}
}
EUVIMED